INSUBCONTINENT EXCLUSIVE:
The mRNA ChulaCOV 19 vaccine which Thailand is developing will enter the first stage of human trials in May with hopes to produce a maximum
of five million shots with its partner, vaccine manufacturer BioNet Asia, by the end of this year.
